Kauffman–White classification

The Kauffmann–White classification or Kauffmann and White classification scheme[1][2] is a system that classifies the genus Salmonella into serotypes, based on surface antigens. It is named after Philip Bruce White and Fritz Kauffmann [de]. First the "O" antigen type is determined based on oligosaccharides associated with lipopolysaccharide. Then the "H" antigen is determined based on flagellar proteins (H is short for the German Hauch meaning "breath" or "mist"; O stands for German ohne meaning "without"). Since Salmonella typically exhibit phase variation between two motile phenotypes,[3] different "H" antigens may be expressed. Salmonella that can express only one "H" antigen phase consequently have motile and non-motile phenotypes and are termed monophasic, whilst isolates that lack any "H" antigen expression are termed non-motile.[4] Pathogenic strains of Salmonella Typhi, Salmonella Paratyphi C, and Salmonella Dublin carry the capsular "Vi" antigen (Vi for virulence),[5] which is a special subtype of the capsule's K antigen (from the German word Kapsel meaning capsule). In 2007, the WHO Collaborating Centre for Reference and Research on Salmonella (WHOCC-Salm), which maintains and updates the classification scheme, and is based in France, proposed that it be renamed the White–Kauffmann–Le Minor scheme, to honor the work of Léon Le Minor [fr], who described most of serovars known at the time.[6]

Kauffmann–White classification for Salmonella

Salmonella (species) serotype (O antigen) : (H1 antigen) : (H2 antigen)
Examples

Salmonella enterica serotype Typhimurium 1,4,5,12:i:1,2

monophasic variant of Salmonella Typhimurium 1,4,5,12:i:-

"O"-group Serovar "O" antigens Phase 1 "H" antigens Phase 2 "H" antigens
A S.Paratyphi A 1,2,12 a no phase 2 antigen
  S. Paratyphi A var. Durazzo 2,12 a no phase 2 antigen
B S. Paratyphi B 1,4,5,12 b 1,2
  S. Paratyphi B var. Odense 1,4,12 b 1,2
  S. Java 1,4,5,12 b (1,2)
  S. Limete 1,4,12,27 b 1,5
  S. Typhimurium 1,4,5,12 i 1,2
  S. Typhimurium var. Copenhagen 1,4,12 i 1,2
  S. Agama 4,12 i 1,6
  S. Abortus-equi 4,12 no phase 1 antigen e,n,x
  S. Abortus-ovis 4,12 c 1,6
  S. Agona 4,12 f,g,s no phase 2 antigen
  S. Brandenburg 4,12 l,v e,n,z15
  S. Bredeney 1,4,12,27 l,v 1,7
  S. Derby 1,4,5,12 f,g no phase 2 antigen
  S. Heidelberg 1,4,5,12 r 1,2
  S. Saintpaul 1,4,5,12 e,h 1,2
  S. Salinatis 4,12 d,e,h d,e,n,z15
  S. Stanley 4,5,12 d 1,2
C1 S. Paratyphi C 6,7,Vi c 1,5
  S. Choleraesuis 6,7 c 1,5
  S. Choleraesuis var. Kunzendorf 6,7 (c) 1,5
  S. Decatur 6,7 c 1,5
  S. Typhisuis 6,7 c 1,5
  S. Bareilly 6,7 y 1,5
  S. Infantis 6,7 r 1,5
  S. Menston 6,7 g,s,t no phase 2 antigen
  S. Montevideo 6,7 g,m,s no phase 2 antigen
  S. Oranienburg 6,7 m,t no phase 2 antigen
  S. Thompson 6,7 k 1,5
C2 S. Bovismorbificans 6,8 r 1,5
  S. Newport 6,8 e,h 1,2
D S. Typhi 9,12,Vi d no phase 2 antigen
  S. Ndolo 9,12 d 1,5
  S. Dublin 1,9,12,Vi[7] g,p no phase 2 antigen
  S. Enteritidis 1,9,12 g,m no phase 2 antigen
  S. Gallinarum 1,9,12 no phase 1 antigen no phase 2 antigen
  S. Pullorum (1),9,12 no phase 1 antigen no phase 2 antigen
  S. Panama 1,9,12 l,v 1,5
  S. Miami 1,9,12 a 1,5
  S. Sendai 1,9,12 a 1,5
E1 S. Anatum 3,10 e,h 1,6
  S. Give 3,10 l,v 1,7
  S. London 3,10 l,v 1,6
  S. Meleagridis 3,10 e,h l,w
E2 S. Cambridge 3,15 e,h l,w
  S. Newington 3,15 e,h 1,6
E3 S. Minneapolis (3),(15),34 e,h 1,6
E4 S. Senftenberg 1,3,19 g,s,t no phase 2 antigen
  S. Simsbury 1,3,19 no phase 1 antigen z27
F S. Aberdeen 11 i 1,2
G S. Cubana 1,13,23 z29 no phase 2 antigen
  S. Poona 13,22 z 1,6
H S. Heves 6,14,24 d 1,5
  S. Onderstepoort 1,6,14,25 e,h 1,5
I S. Brazil 16 a 1,5
  S. Hvittingfoss 16 b e,n,x
Others S. Kirkee 17 b 1,2
  S. Adelaide 35 f,g no phase 2 antigen
  S. Locarno 57 z29 z42
  • Antigens in brackets are those that are rarely expressed in that serovar.

Representative stock of antisera

The cost of maintaining a full set of antisera precludes all but reference laboratories from performing a complete serological identification of salmonella isolates. Most laboratories stock only a limited range of antisera, and the choice of stock sera is largely determined by the nature of the specimens to be processed.

A common set of working antisera is shown below:

O-antisera H-antisera
polyvalent-O, groups A-G polyvalent-H, specific and non-specific
2-O, group A polyvalent-H, non-specific factors 1,2,5,6,7
4-O, group B a-H (S. Paratyphi A)
6, 7-O, group C1 b-H (S. Paratyphi B)
8-O, group C2 c-H (S. Paratyphi C)
9-O, group D d-H (S. Typhi)
3, 10, 15, 19-O group E e,h-H (S. Newport)
11-O, group F f,g-H (S. Derby)
13, 22-O, group G g,m-H (S. Enteritidis)
  i-H (S. Typhimurium)
  k-H (S. Thompson)
  l,v-H (S. London)
  m,t-H (S. Oranienburg)
  r-H (S. Bovismorbificans)

Laboratories that are likely to investigate typhoid also carry antiserum raised against the Vi antigen.

A set of "Rapid Diagnostic Sera" is also held and is used for determination of common specific H-antigens except i-H. After obtaining a positive agglutination with the polyvalent-H specific and non-specific antiserum, the three RDS antisera are used to identify the H antigen present. Depending on the pattern of positive and negative reactions with the RDS antisera, the specific H antigen may be identified:

antigen RDS1 RDS2 RDS3
b agglutination agglutination no agglutination
d agglutination no agglutination agglutination
E agglutination agglutination agglutination
G no agglutination no agglutination agglutination
k no agglutination agglutination agglutination
L no agglutination agglutination no agglutination
r agglutination no agglutination no agglutination

E = polyvalent for eh, enx, etc.
G = polyvalent for gm, gp, etc.
L = polyvalent for lv, lw, etc.

Nonserological correlates

Instead of antibody-based serotyping, modern laborotories increasingly use DNA-based methods such as pulsed field gel electrophoresis, multiple-loci VNTR analysis, multilocus sequence typing, and multiplex-PCR. These "molecular serotyping" systems actually perform genotyping of the genes that determine surface antigens. They largely agree with the Kauffman-White results, allowing the system to continue to be used.[8][9][10][11]

Connection of O and H symbols to the work of Weil and Felix

This use of the O and H symbols is based on the historic observations of Edmund Weil (1879–1922) and Arthur Felix (1887–1956) of a thin surface film produced by agar-grown flagellated Proteus strains, a film that resembled the mist produced by breath on a glass. Flagellated (swarming, motile) variants were therefore designated H forms (German Hauch, for film, literally breath or mist); nonflagellated (nonswarming, nonmotile) variants growing as isolated colonies and lacking the surface film were designated as O forms (German ohne Hauch, without film [i.e., without surface film of mist droplets]).[12][13][14]

References

  1. ^ Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, 1995. Manual of Clinical Microbiology. Washington, DC, ASM Press.
  2. ^ Grimont, Patrick. "Antigenic formulae of the Salmonella serovars, 9th edition". WHO Collaborating Centre for Reference and Research on Salmonella. Archived from the original on 1 July 2013. Retrieved 2 July 2013.
  3. ^ Chiou, C. S.; Huang, J. F.; Tsai, L. H.; Hsu, K. M.; Liao, C. S.; Chang, H. L. (2006). "A simple and low-cost paper-bridged method for Salmonella phase reversal". Diagnostic Microbiology and Infectious Disease. 54 (4): 315–317. doi:10.1016/j.diagmicrobio.2005.10.009. PMID 16466895.
  4. ^ European Food Standards Agency (2010). "Scientific Opinion on monitoring and assessment of the public health risk of "Salmonella Typhimurium-like" strains". EFSA Journal. 8 (10): 7–8. doi:10.2903/j.efsa.2010.1826.
  5. ^ European Food Standards Agency (2010). "Scientific Opinion on monitoring and assessment of the public health risk of "Salmonella Typhimurium-like" strains". EFSA Journal. 8 (10): 7–8. doi:10.2903/j.efsa.2010.1826.
  6. ^ Grimont, Patrick A.D.; Weill, François-Xavier (2007). Antigenic Formulae of the Salmonella Serovars (PDF) (Report) (9 ed.). WHO Collaborating Centre for Reference and Research on Salmonella. Retrieved 2026-01-14.
  7. ^ Grimont, Patrick; Weill, François-Xavier (2007-01-01). "Antigenic Formulae of the Salmonella serovars, (9th ed.) Paris: WHO Collaborating Centre for Reference and Research on Salmonella". Institute Pasteur.: 1–166.
  8. ^ Porwollik S, ed. (2011). Salmonella: From Genome to Function. Caister Academic Press. ISBN 978-1-904455-73-8.
  9. ^ Achtman M, Wain J, Weill FX, Nair S, Zhou Z, Sangal V, Krauland MG, Hale JL, Harbottle H, Uesbeck A, Dougan G, Harrison LH, Brisse S (2012). "Multilocus sequence typing as a replacement for serotyping in Salmonella enterica". PLOS Pathogens. 8 (6) e1002776. doi:10.1371/journal.ppat.1002776. PMC 3380943. PMID 22737074. Open access icon
  10. ^ Luo Y, Huang C, Ye J, Octavia S, Wang H, Dunbar SA, Jin D, Tang YW, Lan R (2020-09-07). "Comparison of xMAP Salmonella Serotyping Assay With Traditional Serotyping and Discordance Resolution by Whole Genome Sequencing". Frontiers in Cellular and Infection Microbiology. 10 452. doi:10.3389/fcimb.2020.00452. PMC 7504902. PMID 33014887.
  11. ^ Nair S, Patel V, Hickey T, Maguire C, Greig DR, Lee W, Godbole G, Grant K, Chattaway MA (August 2019). Ledeboer NA (ed.). "Real-Time PCR Assay for Differentiation of Typhoidal and Nontyphoidal Salmonella". Journal of Clinical Microbiology. 57 (8) e00167–19. doi:10.1128/JCM.00167-19. PMC 6663909. PMID 31167843.
  12. ^ Weil, E. & Felix, A. (1917) Wien. Klin. Wschr. 30, 1509, cited in Smith, R.W. & Koffler, H., "Bacterial Flagella", in Advances in Microbial Physiology, Vol. 6 (A.H. Rose & J.F. Wilkinson, Eds.), p. 251, Academic Press, 1971
  13. ^ Rietschel, E.T. & Westphal, O. "Endotoxin: Historical Perspectives", in Endotoxin in Health Disease (H. Brade, Ed.), p. 11, CRC Press, 1999.
  14. ^ Hahon, N., Ed. Selected Papers on the Pathogenic Rickettsiae, p. 79, Harvard University Press, 1968.